Forza Innovations Inc. (FORZ)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Forza Innovations Inc. (FORZ) trades at $0.00 with AI Score 69/100 (Grade B+). Forza Innovations Inc. operates in the health-tech wearable performance sector, offering its WarmUp series of back compression devices. Market cap: $252,183, Sector: Healthcare.
Price live · AI analysis from Jun 13, 2026Analyst Coverage for FORZ: FORZ does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates FORZ against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
FORZ: the 7 perspectives are evenly split. Dominant signal: Ken Griffin bearish.
How is this calculated? →Forza Innovations Inc. (FORZ) Healthcare & Pipeline Overview
Forza Innovations Inc. (FORZ) is a San Diego-based health-tech company specializing in wearable performance devices, specifically the WarmUp series of back compression products. Incorporated in 2014, the company's offerings, including the J4 Sport, J4 X, and J4 Fitbelt, are designed to address muscle stiffness and soreness, positioning it within the niche market of therapeutic wearables.
What Is the Investment Thesis for FORZ?
Forza Innovations Inc. operates in the health-tech wearable performance segment, offering its WarmUp series of back compression devices designed for muscle relaxation and recovery. The company's gross margin of 76.5% indicates strong product-level profitability, suggesting efficient cost management relative to its revenue stream. However, a significant profit margin of -4150.0% highlights substantial operational expenses or limited revenue generation, leading to considerable net losses. The beta of 0.83 suggests lower volatility compared to the broader market, which might appeal to certain investor profiles. Key growth catalysts could stem from increased adoption of wearable health technologies and a growing consumer focus on non-pharmacological pain and stiffness relief. The market for therapeutic wearables continues to expand, driven by aging populations and increased athletic participation. Value drivers include potential product line expansion within the wearable health space and enhanced market penetration for its existing WarmUp series. Risks include its current lack of profitability, small operational scale with only two employees, and the competitive landscape of the medical device and consumer health sectors. The company's ability to scale operations and achieve positive net income will be critical for long-term viability and investor returns.
Based on FMP financials and quantitative analysis
FORZ Key Highlights
- Gross Margin of 76.5% indicates strong product-level profitability.
- Profit Margin of -4150.0% reflects significant operational losses relative to revenue.
- Market Capitalization is $0.00B, suggesting a micro-cap or pre-revenue stage.
- Beta of 0.83 indicates lower stock price volatility compared to the overall market.
- Operates with a lean team of 2 employees, highlighting a highly focused or early-stage operational structure.
Who Are FORZ's Competitors?
FORZ is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| DCTH Delcath Systems, Inc. | $13.61 | +3.11% | $469.84M | 73 |
| PYNKF Perimeter Medical Imaging AI, Inc. | $0.20 | +3.40% | $18.68M | 73 |
| SSII SS Innovations International, Inc. | $3.76 | -0.53% | $752.49M | 72 |
| RSHUF Respiri Limited | $0.06 | +0.00% | $91.52M | 68 |
| DNAY Codex DNA, Inc. | $1.30 | +8.33% | $38.32M | 68 |
| PROF Profound Medical Corp. | $7.21 | +5.87% | $218.16M | 67 |
| SENS Senseonics Holdings, Inc. | $5.66 | +3.36% | $236.74M | 67 |
| BWAY BrainsWay Ltd. | $16.02 | +5.46% | $628.35M | 66 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are FORZ's Key Strengths?
- Specialized product line addressing muscle comfort and recovery.
- High gross margin of 76.5% indicates efficient product cost structure.
- Lean operational structure with 2 employees.
- Positioned in the growing health-tech wearable market.
What Are FORZ's Weaknesses?
- Significant negative profit margin of -4150.0% indicating substantial losses.
- Extremely small operational scale with only two employees.
- Market capitalization of 252K suggests very limited financial scale.
- Unknown disclosure status on OTC market.
What Could Drive FORZ Stock Higher?
- Potential product line expansion within the therapeutic wearables market.
- Formation of strategic partnerships for broader distribution or co-branding.
- Continued market penetration and adoption of the WarmUp series products.
- Any future disclosures regarding financial performance or operational updates.
What Are the Key Risks for FORZ?
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Significant negative profit margin of -4150.0% indicating substantial operational losses.
- Limited operational scale with only two employees, potentially hindering growth and scalability.
- Intense competition from well-capitalized companies in the health-tech and medical device sectors.
- Challenges in securing additional funding to support operations and growth initiatives.
- Regulatory and disclosure uncertainties associated with trading on the OTC Other tier.
What Are the Growth Opportunities for FORZ?
- Expansion into Adjacent Therapeutic Wearables: The market for therapeutic wearables extends beyond back compression to include devices for joint support, muscle stimulation, and localized pain relief across various body parts. Forza Innovations could leverage its expertise in wearable technology to develop new products targeting knees, shoulders, or wrists, tapping into a broader segment of the musculoskeletal health market. This expansion could significantly increase its total addressable market, which is part of the global wearable medical device market projected to reach tens of billions of dollars by the early 2030s, offering substantial long-term revenue potential.
- Penetration of Professional Sports and Rehabilitation Markets: While currently positioned for general consumer use, the WarmUp series could be marketed to professional sports teams, athletic trainers, and physical therapy clinics. These segments often require high-performance, durable, and clinically effective devices for injury prevention, recovery, and rehabilitation. Establishing partnerships or securing endorsements within these professional spheres could validate the product's efficacy and significantly boost brand credibility and sales volume. This strategy targets a premium segment with higher purchasing power and a consistent need for advanced recovery tools.
- Leveraging E-commerce and Direct-to-Consumer Channels: With a lean operational structure, Forza Innovations can maximize its reach and profitability by focusing on robust e-commerce strategies. Direct-to-consumer sales eliminate intermediary costs and allow for direct engagement with customers, gathering valuable feedback for product iteration and marketing. Investing in digital marketing, search engine optimization, and social media campaigns can expand market awareness and drive online sales, particularly within the health and fitness communities. This approach offers a cost-effective path to scale in a global marketplace.
- Strategic Partnerships with Wellness and Fitness Brands: Collaborating with established wellness brands, fitness centers, or even chiropractic networks could provide Forza Innovations with immediate access to a wider customer base and distribution channels. These partnerships could involve co-branding, bundled product offerings, or exclusive distribution agreements. For instance, integrating the WarmUp series into recovery programs offered by gyms or wellness retreats could introduce the product to health-conscious consumers who are actively seeking solutions for muscle care, creating synergistic marketing opportunities and expanding market penetration.
- Technological Enhancements and Smart Features: Integrating "smart" features into the WarmUp series, such as temperature control, vibration therapy, or connectivity to health tracking apps, could significantly enhance product value and differentiation. The global smart wearable market is continuously evolving, with consumers increasingly seeking devices that offer data-driven insights and personalized experiences. Developing next-generation products with advanced sensors or AI-driven feedback could position Forza as an innovator in the therapeutic wearable space, commanding higher price points and attracting tech-savvy consumers looking for integrated health solutions.
What Opportunities Does FORZ Have?
- Expansion into adjacent therapeutic wearable markets.
- Penetration into professional sports and rehabilitation sectors.
- Leveraging e-commerce for direct-to-consumer sales growth.
- Strategic partnerships with wellness and fitness brands.
What Threats Does FORZ Face?
- Intense competition from established medical device companies and consumer electronics giants.
- Potential for new entrants with superior technology or marketing.
- Regulatory hurdles and compliance costs in the medical device industry.
- Reliance on a single product line (WarmUp series).
What Are FORZ's Competitive Advantages?
- Specialized focus on wearable back compression devices within the health-tech sector.
- Proprietary design and technology of the WarmUp series products.
- Brand recognition established through its specific product line.
What Does FORZ Do?
Forza Innovations Inc., originally incorporated as Genesys Industries, Inc. in 2014, underwent a significant rebranding in June 2021 to reflect its sharpened focus on the health-tech wearable performance market. Headquartered in San Diego, California, the company has strategically positioned itself within the burgeoning medical devices industry, specifically targeting solutions for muscle comfort and recovery. Its core product line, known as the WarmUp series, encompasses a range of wearable back compression devices. These innovative products, which include the J4 Sport, J4 X, and J4 Fitbelt, are engineered to provide targeted relief and support. The primary function of these devices is to assist users in relaxing, warming up, loosening, or alleviating stiff and sore muscles, catering to a diverse user base from athletes seeking pre-activity preparation to individuals experiencing everyday muscular discomfort. The company's evolution from its prior identity to Forza Innovations Inc. underscores a commitment to developing specialized, non-invasive health solutions. Despite its lean operational structure, with a reported two employees, Forza Innovations Inc. aims to carve out a distinct niche by offering accessible and user-friendly wearable technology. The company's strategy revolves around the utility and effectiveness of its WarmUp series, which addresses a common physiological need for muscle care. By focusing on wearable technology, Forza Innovations Inc. aligns with broader trends in healthcare towards preventative and self-managed wellness solutions. Its products are designed for direct consumer use, emphasizing ease of application and immediate benefits for muscle relaxation and recovery.
What Products and Services Does FORZ Offer?
- Develops and sells health-tech wearable performance devices.
- Offers the WarmUp series product line.
- Manufactures wearable back compression devices.
- Products include the J4 Sport, J4 X, and J4 Fitbelt.
- Devices are designed to relax stiff and sore muscles.
- Aids in warming up and loosening muscles.
- Operates in the medical devices industry.
How Does FORZ Make Money?
- Generates revenue through the direct sale of its WarmUp series wearable devices.
- Focuses on the health-tech and muscle recovery consumer market.
- Likely employs a direct-to-consumer sales model, potentially supplemented by retail partnerships.
What Industry Does FORZ Operate In?
Forza Innovations Inc. operates within the "Medical - Devices" industry, a sub-segment of the broader Healthcare sector. This industry is characterized by innovation in diagnostic, therapeutic, and assistive technologies. The global wearable medical device market, a key segment for Forza, is experiencing robust growth, driven by increasing health consciousness, the rise of chronic diseases, and technological advancements. These devices offer solutions for monitoring, prevention, and therapy, often empowering individuals with greater control over their health. Forza's WarmUp series positions it within the niche of therapeutic wearables focused on muscle recovery and pain relief. The competitive landscape includes established medical device manufacturers, specialized sports recovery brands, and emerging health-tech startups. Forza's challenge is to differentiate its back compression devices in a market where efficacy, comfort, and user experience are paramount, while also navigating regulatory considerations pertinent to medical devices.
Who Are FORZ's Key Customers?
- Individuals seeking relief from stiff and sore muscles.
- Athletes and fitness enthusiasts for warm-up and recovery.
- Consumers interested in non-pharmacological muscle comfort solutions.
How Forza Innovations Inc. Is Valued
Forza Innovations Inc. carries a market capitalization of 252K, placing it in the micro-cap category. Relative to its peer group, FORZ's quantitative score of 69/100 is roughly in line with the peer average of 71/100.
Company Profile
Forza Innovations Inc. operates in the Medical - Devices industry within the Healthcare sector. It is headquartered in San Diego, US. The company is led by CEO Evan Schick. FORZ has traded publicly since 2019.
ROE 160%Key Financial Metrics
Return on equity for Forza Innovations Inc. stands at 160.3%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching.
F-Score 3/9Financial Health
Forza Innovations Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
Net buyingInsider Activity
The most recent 12 insider filings for Forza Innovations Inc. break down as 8 sales and 4 purchases. On net that is roughly 1.9M shares acquired (about $86K) — insiders putting money in tends to read as conviction.
FORZ Financials
Bull Case vs Bear Case
Bull Case
- Specialized product line addressing muscle comfort and recovery.
- High gross margin of 76.5% indicates efficient product cost structure.
- Lean operational structure with 2 employees.
- Positioned in the growing health-tech wearable market.
Bear Case
- Significant negative profit margin of -4150.0% indicating substantial losses.
- Extremely small operational scale with only two employees.
- Market capitalization of 252K suggests very limited financial scale.
- Unknown disclosure status on OTC market.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
FORZ Latest News
No recent news available for FORZ.
FORZ Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for FORZ.
Price Targets
Wall Street price target analysis for FORZ.
FORZ MoonshotScore
What does this score mean?
The MoonshotScore rates FORZ's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Evan Schick
CEO
Evan Schick serves as the Chief Executive Officer of Forza Innovations Inc., leading the company's strategic direction and day-to-day operations. While specific details regarding his prior career history, educational background, or previous executive roles are not explicitly provided in the available data, his current role involves managing the company's lean team of two employees. This suggests a hands-on leadership approach within a small, focused organization. His leadership is central to the company's efforts in developing and marketing its health-tech wearable performance products, particularly the WarmUp series of back compression devices.
Track Record: Under Evan Schick's leadership, Forza Innovations Inc. has focused on the development and commercialization of its WarmUp series, including the J4 Sport, J4 X, and J4 Fitbelt. A notable milestone was the company's rebranding from Genesys Industries, Inc. to Forza Innovations Inc. in June 2021, signifying a strategic pivot towards health-tech wearables. His management oversees the operations of the company with a small team, indicating a concentrated effort on product execution and market positioning within the medical devices industry.
FORZ OTC Market Information
Forza Innovations Inc. trades on the OTC market under the "OTC Other" tier. This tier is for companies that do not meet the disclosure requirements for OTCQX or OTCQB, or that do not qualify for the Pink Open Market. Companies in the OTC Other tier may not provide current or publicly available information to investors, which can lead to limited transparency. Unlike major exchanges like NYSE or NASDAQ, which have stringent listing standards regarding financial health, corporate governance, and disclosure, the OTC Other tier has minimal to no such requirements, making it a market with significantly less oversight.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited public information and disclosure due to "OTC Other" tier.
- Potentially low trading volume and wide bid-ask spreads, impacting liquidity.
- Increased susceptibility to fraud and manipulation due to reduced regulatory oversight.
- Difficulty in obtaining reliable valuation metrics and financial data.
- Higher volatility compared to exchange-listed securities.
- Verify current financial statements and disclosures directly from the company, if available.
- Research any past regulatory actions or enforcement against the company or management.
- Assess the company's business operations and product viability independently.
- Investigate management's background and track record beyond provided data.
- Understand the specific risks associated with the "OTC Other" tier.
- Seek independent legal and financial advice before considering investment.
- Incorporated in 2014, indicating a history of operation.
- Headquartered in San Diego, California, a known hub for innovation.
- Has a defined product line (WarmUp series) in a specific health-tech niche.
Forza Innovations Inc. Healthcare Stock: Key Questions Answered
What does Forza Innovations Inc. do?
Forza Innovations Inc. is a health-tech company based in San Diego, California, specializing in wearable performance devices. Its primary offering is the WarmUp series, which includes products like the J4 Sport, J4 X, and J4 Fitbelt. These are wearable back compression devices designed to provide therapeutic benefits such as relaxing, warming up, loosening, or alleviating stiff and sore muscles. The company operates within the medical devices industry, targeting consumers seeking non-invasive solutions for muscle comfort and recovery. Incorporated in 2014 and rebranded in 2021, Forza Innovations focuses on a niche within the growing wearable health technology market.
How does Forza Innovations Inc. differentiate its WarmUp series in the competitive health-tech market?
Forza Innovations Inc. differentiates its WarmUp series by focusing on a specific application: wearable back compression for muscle relaxation and recovery. While the broader health-tech market is vast, Forza's products are tailored to address a common need for alleviating stiffness and soreness. Its reported gross margin of 76.5% suggests a potentially efficient production process or strong pricing power, which could be a differentiator. The company's strategy appears to center on the direct utility and effectiveness of its specialized devices, aiming to provide a clear, tangible benefit for users seeking targeted muscle care without complex features, positioning itself as a focused solution provider in a market often saturated with multi-functional gadgets.
What are the main risks for FORZ?
Forza Innovations Inc. faces several significant risks. Operationally, the company's extremely lean structure with only two employees presents challenges for scaling, product development, and market reach. Financially, a profit margin of -4150.0% indicates substantial ongoing losses, raising concerns about long-term sustainability and the need for future capital infusions. Furthermore, trading on the "OTC Other" tier means limited public disclosure and transparency, which can deter institutional investors and expose shareholders to higher liquidity risks, wider bid-ask spreads, and potential market manipulation. The competitive landscape of the medical device and health-tech wearable industry also poses a threat, with larger, better-funded companies potentially dominating market share.
Given its small operational size, how does Forza Innovations Inc. plan to scale its business?
While the provided data does not explicitly detail Forza Innovations Inc.'s scaling strategy, a company with only two employees typically relies on highly efficient processes, outsourcing, and strategic partnerships to grow. Potential scaling avenues could include leveraging e-commerce platforms for direct-to-consumer sales to reach a wider audience without expanding a large physical sales force. Additionally, forming alliances with distributors, wellness brands, or athletic organizations could provide access to established customer bases and distribution networks. Focusing on a niche product line like the WarmUp series allows for concentrated marketing efforts and resource allocation, aiming for deep market penetration in its specific segment before potentially diversifying or expanding operations.
What are the key factors to evaluate for FORZ?
Forza Innovations Inc. (FORZ) holds an AI score of 69/100 (moderate). Not financial advice.
How frequently does FORZ data refresh on this page?
FORZ prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven FORZ's recent stock price performance?
Forza Innovations Inc. (FORZ) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Specialized product line addressing muscle comfort and recovery. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider FORZ overvalued or undervalued right now?
Valuing Forza Innovations Inc. (FORZ) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- No FMP peer tickers were provided in the source data.
- Specific details on CEO's background, education, and tenure were not provided.
- Analyst ratings or price targets were not available in the source data.